Search

everythinglearnresearchcommunity

for

Search:↓

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Cetosomal minoxidil alone and with finasteride is effective and well-tolerated for hair loss treatment.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

The liposomal hydrogel shows promise for hair loss treatment but needs more testing.

Oral retinoids like isotretinoin and acitretin can cause significant hair loss.

Rb-bFGF improves hair transplant results and patient satisfaction with fewer complications.

Ethosomes are effective for delivering drugs through the skin by penetrating deeply and targeting hair follicles.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

A new hair loss treatment was created using minoxidil and tretinoin in stable niosomes, which effectively released the drugs over time.

Topical minoxidil may help improve hair growth in rare congenital hypotrichosis.

Liposomes improve minoxidil delivery to hair follicles, enhancing treatment for hair loss.

Peptide hydrogels show promise for healing skin, bone, and nerves but need improvement in stability and compatibility.

New hair loss treatments could be improved by using combined biological markers.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Nanotechnology shows promise for better chronic wound healing but needs more research.

3D-printed microneedles improve drug delivery and diagnostics but face scalability and regulatory challenges.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Mesotherapy is a skin injection therapy used for pain and local conditions, with scientific support but needing more clinical trials.

Microneedles are becoming essential tools in medicine for sensing, drug delivery, and communication.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Laser hair removal is popular for long-term hair reduction but carries risks, requiring well-trained operators and better regulations, especially in South Africa.

Innovative cosmetics could safely change hair color by targeting biological hair pigmentation processes.

Nilotinib can cause keratosis pilaris, a skin condition.